06:04 EDT Tonix Pharmaceuticals (TNXP) files $500M mixed securities shelf
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TNXP:
- Tonix Pharma Signs Major Sales Agreements for Funding
- Tonix Pharmaceuticals price target raised to $65 from $11 at Alliance Global Partners
- Tonix Pharma Begins Phase 2 OASIS Trial
- Tonix Pharmaceuticals announces first patient dosed in Phase 2 OASIS study
- Tonix, Illumina, HP, Schwab & Carvana: Insider Moves!